Show simple item record

dc.contributor.authorSedef, Ali Murat
dc.contributor.authorKose, Fatih
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorDogan, Ozlem
dc.contributor.authorKursun, Ebru
dc.contributor.authorYurdakul, Zafer
dc.contributor.authorGultepe, BİLGE
dc.contributor.authorMertsoylu, Huseyin
dc.contributor.authorSezer, Ahmet
dc.contributor.authorOzyilkan, Ozgur
dc.date.accessioned2019-10-05T14:13:07Z
dc.date.available2019-10-05T14:13:07Z
dc.date.issued2016-05-01
dc.identifier10.1046/j.1469-0691.2002.00371.x
dc.identifier.urihttps://hdl.handle.net/20.500.12645/3270
dc.description.abstractPurpose: Infectious diseases are a major cause of morbidity and mortality in cancer patients. Tumor-induced inflammatory responses may increase the value of classical inflammatory markers in blood, so these markers may not be as useful in cancer patients as in non-cancer patients. Serum procalcitonin (PCT) is a sensitive and specific biomarker for severe infection, and has been shown to be unaffected by tumor-induced inflammatory response. In this study we aimed to evaluate the possible role of PCT in mortality in cancer patients with infection.
dc.language.isoen
dc.subjectSedef A. M. , Kose F., Sumbul A. T. , Dogan O., Kursun E., Yurdakul Z., Gultepe B., Mertsoylu H., Sezer A., Ozyilkan O., -Prognostic value of procalcitonin in infection-related mortality of cancer patients-, JOURNAL OF BUON, cilt.21, ss.740-744, 2016
dc.titlePrognostic value of procalcitonin in infection-related mortality of cancer patients
dc.typeArticle
local.avesis.response3140
local.article.journalnameCLINICAL MICROBIOLOGY AND INFECTION
dc.contributor.institutionauthorSÜMBÜL, BİLGE


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record